References
- Menter A, Korman NJ, Elmets CA, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies. J Am Acad Dermatol. 2009;60(4):643–659.
- Enbrel® (etanercept) product information. Thousand Oaks, CA: Amgen Inc; 2013.
- Humira® (adalimumab) injection product information. North Chicago, IL: Abbvie Inc; 2016.
- Jackson R. Current concepts in dermatology III: the use of radiotherapy and corticosteroids. Can Med Assoc J. 1963;89:888–892.
- Nordwall C. Local treatment of psoriasis and eczema with betamethasone-17,21-dipropionate (Diproderm cream): a double-blind comparison with fluocortolone caproate, fluocortolone pivalate (Ultralanum cream). Curr Ther Res Clin Exp. 1974;16(8):798−803.
- Diprolene® lotion (augmented betamethasone dipropionate 0.05%) product information. Kenilworth, NJ: Schering Corporation; 1999.
- Sernivo™ (betamethasone dipropionate) spray, 0.05% product information. Princeton, NJ: Promius Pharma LLC; 2016.
- Stein Gold L, Jackson JM, Knuckles ML, et al. Improvement in extensive moderate plaque psoriasis with a novel emollient spray formulation of betamethasone dipropionate 0.05. J Drugs Dermatol. 2016;15(3):334−342.
- Fowler JF Jr, Hebert AA, Sugarman J. DFD-01, a novel medium potency betamethasone dipropionate 0.05% emollient spray, demonstrates similar efficacy to augmented betamethasone dipropionate 0.05% lotion for the treatment of moderate plaque psoriasis. J Drugs Dermatol. 2016;15(2):154–162.
- Feldman SR, Krueger GG. Psoriasis assessment tools in clinical trials. Ann Rheum Dis. 2005;64(Suppl 2):ii65–ii68.
- Langley RG, Feldman SR, Nyirady J, et al. The 5-point Investigator’s Global Assessment (IGA) scale: a modified tool for evaluating plaque psoriasis severity in clinical trials. J Dermatolog Treat. 2015;26(1):23–31.
- Kircik L, Lebwohl MG, Del Rosso JQ, et al. Clinical study results of desoximetasone spray, 0.25% in moderate to severe plaque psoriasis. J Drugs Dermatol. 2013;12(12):1404–1410.
- Menter A, Abramovits W, Colón LE, et al. Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis. J Drugs Dermatol. 2009;8(1):52–57.
- Clobex® (clobetasol dipropionate) spray product information. Fort Worth, TX: Galderma Laboratories; 2012.
- Menter A. Clobetasol propionate 0.05% spray for the treatment of moderate to severe plaque psoriasis. Cutis. 2012;89(2):89–94.
- National Psoriasis Foundation [Internet]. About Psoriasis: How Severe is my Psoriasis? Portland (OR): National Psoriasis Foundation/USA; c1996−2016; [cited 2016 Sep 4]; [ about 10 screens]. Available from: https://www.psoriasis.org/about-psoriasis
- National Psoriasis Foundation [Internet]. Moderate to severe psoriasis and psoriatic arthritis: biologic drugs Portland (OR): National Psoriasis Foundation/USA; c1996−2016.; [cited 2016 Sep 7]; [ about 5 screens]. Available from: https://www.psoriasis.org/about-psoriasis/treatments/biologics
- McKenzie AW, Stoughton RB. Method for comparing percutaneous absorption of steroids. Arch Dermatol. 1962;86(5):608−610.
- Kenalog® (triamcinolone acetonide) topical aerosol spray. Jacksonville, FL: Ranbaxy; 2011.
- Luxiq® (betamethasone valerate) foam 0.12% product information. Research Triangle Park, NC: Stiefel Laboratories Inc; 2013.
- Topicort® (Desoximetasone) ointment USP 0.05% product information. Hawthorne, NY: Taro Pharmaceuticals; 2013.
- Levin E, Gupta R, Butler D, et al. Topical steroid risk analysis: differentiating between physiologic and pathologic adrenal suppression. J Dermatolog Treat. 2014;25(6):501–506.
- Castela E, Archier E, Devaux S, et al. Topical corticosteroids in plaque psoriasis: a systematic review of risk of adrenal axis suppression and skin atrophy. J Eur Acad Dermatol Venereol. 2012;26(Suppl3):47–51.
- Kansky A. The effects of increased penetration of betamethasone dipropionate in a propylene glycol base (Diprolene) for psoriasis. J Int Med Res. 1981;9(2):128–131.